CM Life Sciences III (CMLT) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
bizjournals.com logoNew life sciences initiative targets local industry growth, talent pipeline acceleration
bizjournals.com - March 8 at 2:38 PM
benzinga.com logoTechnical Writing Excellence in the Life Sciences - A Masterclass (November 2-3, 2023)
benzinga.com - November 17 at 6:53 PM
bizjournals.com logoInterest in life sciences space in the Triangle remains intense
bizjournals.com - August 13 at 12:18 AM
msn.com logo(LEAD) Samsung Life Insurance Q2 net jumps 70.3 pct
msn.com - August 12 at 8:24 AM
apnews.com logoIpsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer
apnews.com - August 3 at 2:16 AM
news.yahoo.com logoBaby formula available at Beginnings Care for Life Center in Coldwater
news.yahoo.com - May 17 at 6:07 PM
reuters.com logoEQRx Inc
reuters.com - December 27 at 2:19 PM
benzinga.com logoCM Life Sciences III Merger Partner EQRx Debuts On Nasdaq
benzinga.com - December 19 at 6:11 PM
finance.yahoo.com logoEQRx and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination
finance.yahoo.com - December 2 at 7:23 AM
finance.yahoo.com logoEQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference
finance.yahoo.com - November 29 at 8:21 AM
wsj.com logoCM Life Sciences III Inc. Cl A
wsj.com - October 28 at 12:18 AM
finance.yahoo.com logoEQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
finance.yahoo.com - October 6 at 12:15 PM
finance.yahoo.com logoEQRx Appoints Kathy Giusti to Board of Directors
finance.yahoo.com - September 27 at 8:09 AM
nasdaq.com logoCM Life Sciences III Inc - Class A Shares Close in on 52-Week Low - Market Mover
nasdaq.com - September 22 at 9:52 AM
finance.yahoo.com logoEQRx Announces Presentation of Updated Data from Pivotal Phase 3 Study of Anti-PD-L1 Antibody Sugemalimab in Combination with Chemotherapy as a First-Line Treatment for Stage IV NSCLC
finance.yahoo.com - September 13 at 10:36 PM
finance.yahoo.com logoEQRx to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
finance.yahoo.com - September 7 at 8:54 AM
nasdaq.com logoCM Life Sciences III Inc - Class A Shares Approach 52-Week Low - Market Mover
nasdaq.com - August 28 at 7:36 PM
nasdaq.com logoKeith Meister-backed SPAC to merge with biotech firm EQRx in $3.65 bln deal
nasdaq.com - August 6 at 9:41 AM
marketbeat.com logo
marketbeat.com - August 6 at 7:02 AM
Get CM Life Sciences III News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMLT and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

CMLT Media Mentions By Week

CMLT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CMLT
News Sentiment

0.00

0.46

Average
Medical
News Sentiment

CMLT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CMLT Articles
This Week

0

0

CMLT Articles
Average Week

Get CM Life Sciences III News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMLT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CMLT) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners